NorthWest Biotherapeutics Inc (NWBO)

[newman2021]

yep, on page 28/29 I love this like you pointed out.

'As of September 30, 2023, the only unvested milestone was to submit an application to a regulatory which is expected to take place during November 2023'

And also on page 25, I love this.
Between May and September 2023, the Company entered into certain non-dilutive funding agreements with multiple investors, pursuant to which the Company received funding of $4.6 million related to a gain contingency. These agreements are accounted for under ASC 470 and are recognized as contingent payment obligations on the Company’s condensed consolidated balance sheet. The Company’s payment obligations only apply when such are received by the Company.